| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $454K | -95.5% |
| SG&A Expense | $9.7M | +39.9% |
| Operating Income | -$24.3M | -43.1% |
| Pre-tax Income | -$22.4M | +3.9% |
| Income Tax | $2K | +0.0% |
| Net Income | -$22.4M | +3.7% |
| EPS (Basic) | -$0.70 | +33.3% |
| EPS (Diluted) | -$0.70 | +33.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $9.7M | -4.4% |
| Total Assets | $9.7M | -4.4% |
| Current Liabilities | $5.8M | +52.4% |
| Total Liabilities | $7.3M | +12.4% |
| Stockholders' Equity | $2.4M | -34.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.8M | -20.0% |
| Financing Cash Flow | $17.9M | -1.5% |